12.19.2019 - By ReachMD
Host: Matt Birnholz, MD
Guest: Lauren Nye, MD
Considering there’s little known about the breast microenvironment during pregnancy and whether this plays into future breast cancer risk, Dr. Lauren Nye's team examined whether omega 3 supplements as potential non-teratogenic chemoprevention agents could accentuate the protective changes on breast cancer risk that occur with hormonal fluctuations during pregnancy. And Dr. Matt Birnholz was there at the 2019 San Antonio Breast Cancer Symposium to catch up with Dr. Nye about this study.